-+ 0.00%
-+ 0.00%
-+ 0.00%

Lyell Immunopharma CMO Jarrad Mattieu Aguirre files initial beneficial ownership statement

PUBT·09/10/2026 23:30:38
Listen to the news
Lyell Immunopharma CMO Jarrad Mattieu Aguirre files initial beneficial ownership statement
  • Lyell Immunopharma Chief Medical Officer Jarrad Mattieu Aguirre reported direct ownership of 20,279 common shares in an initial SEC filing.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lyell Immunopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002150331-26-000001), on September 10, 2026, and is solely responsible for the information contained therein.